FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

784411004: Caplacizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3764507011 Caplacizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3764508018 Caplacizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3764507011 Caplacizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3764508018 Caplacizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5592341000241115 caplacizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5592341000241115 caplacizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caplacizumab (substance) Has disposition Platelet aggregation inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Caplacizumab (substance) Is a Platelet aggregation inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Caplacizumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Caplacizumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Caplacizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Caplacizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Caplacizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Caplacizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Caplacizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Caplacizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Caplacizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start